Jim Cramer on Agilent Technologies: “I Don’t Think You Need It”

You know, they bash truthful overmuch trial and measurement that is biotech. It’s astir similar a Danaher, which stopped working. Danaher, Agilent, I don’t deliberation you request it.

A banal marketplace chart. Photo by Arturo A connected Pexels

Agilent Technologies, Inc. (NYSE:A) provides instruments, software, and services for beingness sciences, diagnostics, and chemic analysis, including chromatography, spectroscopy, genomics, and laboratory automation solutions. Cramer discussed the pre- and post-COVID show of the banal during the December 1, 2025, arsenic helium said:

Last week, conscionable earlier Thanksgiving, I got the accidental to talk with Agilent Technologies. That’s an arms trader to the beingness sciences industry. A agelong clip ago, this stock, known arsenic missive A for its banal symbol, was a large maturation vehicle. In the decennary earlier COVID, Agilent’s illustration was conscionable a happening of beauty. Then, erstwhile the pandemic got rolling, the banal roared adjacent higher, and ever since the pandemic receded, things got choppy for this 1 but besides for the full industry. The beingness sciences companies had each the instrumentality they needed, truthful the full radical spent years successful the canine house.

While we admit the imaginable of A arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the champion short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. Follow Insider Monkey connected Google News.